Showing results (261-270 of 302) with videos related to
Sort By:
Pageof 31
Cancer|November 10, 2020
Associations of baseline patient-reported outcomes with treatment outcomes in advanced gastrointestinal cancerEmily E van Seventer, Madeleine G Fish, Kathryn Fosbenner, et al.Journal of the National Cancer Institute|June 5, 2020
Tumor Microenvironment Immune Response in Pancreatic Ductal Adenocarcinoma Patients Treated With Neoadjuvant TherapyTheodoros Michelakos, Lei Cai, Vincenzo Villani, et al.Nature|July 6, 2012
RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasisMin Yu, David T Ting, Shannon L Stott, et al.American Journal of Clinical Oncology|May 20, 2024
Hypofractionated Radiotherapy-Related Lymphopenia Is Associated With Worse Survival in Unresectable Intrahepatic CholangiocarcinomaGrace Lee, Daniel W Kim, Alicia C Smart, et al.The Oncologist|May 10, 2013
FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experienceJason E Faris, Lawrence S Blaszkowsky, Shaunagh McDermott, et al.JCO Oncology Practice|May 27, 2021
Care Patterns and Overall Survival in Patients With Early-Onset Metastatic Colorectal CancerKatie Kanter, Madeleine Fish, Gianluca Mauri, et al.The Oncologist|August 22, 2020
Revisiting MET: Clinical Characteristics and Treatment Outcomes of Patients with Locally Advanced or Metastatic, MET-Amplified Esophagogastric CancersSurendra Pal Chaudhary, Eunice L Kwak, Katie L Hwang, et al.Journal of the National Cancer Institute|September 17, 2015
Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical TrialCarmen J Allegra, Greg Yothers, Michael J O'Connell, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2017
Use of Angiotensin System Inhibitors Is Associated with Immune Activation and Longer Survival in Nonmetastatic Pancreatic Ductal AdenocarcinomaHao Liu, Kamila Naxerova, Matthias Pinter, et al.Proceedings of the National Academy of Sciences of the United States of America|January 19, 2017
An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinomaMark Kalinich, Irun Bhan, Tanya T Kwan, et al.Pageof 31